Skip to the content.

Overview

Welecome to MLST_MicroSoc_2022 repository and thank you for expressing your interest in our research! :wave: :microscope: :relaxed: :woman_technologist:

This is the repository where you can find supplementary data for poster presented at the Microbiology Society Annual Conference 2022.


Introduction

Why are Streptomyces important?

The global crisis of antibiotic resistance (AMR) contributes to over 700,000 deaths annually. If left unchecked, AMR will become the leading global cause of death by 2050, killing over 10 million people. A recent discovery showed that Streptomyces sp. SM01 possesses the ability to produce a novel antibiotic picolinamycin with antimicrobial activity against drug-resistant bacterial strains. Additionally, members of the genus Streptomyces are prolific producers of a variety important bioactive compounds, accounting for the synthesis of over 80% of all clinically approved bioactive compounds. Interest in Streptomyces species significantly increased after discovering their production of the antimicrobial compound streptomycin, and chemotherapy medication actinomycin. Over 650 species in the family of Streptomycetaceae have been identified. These are potential reservoirs of novel drugs. Genes involved in synthesis of bioactive compounds can be mined from these bacterial genomes and, as the number of sequenced Streptomyces genomes increased in the past decade, this has had a significant beneficial impact on drug discovery.

A powerful way to discover pharmaceutically-important compounds is to find and identify genes responsible for their synthesis by comparing complete genome sequences of various species. In addition, this approach helps avoid “rediscovery” of known compounds and prioritises compounds with potential novel clinical activity for extensive laboratory work from closely related genomic sequences. However, the exact relationships between Streptomyces species are currently poorly defined, and many species are incorrectly named.

Multilocus Sequence Typing

Multilocus sequence typing (MLST) is widely used to characterise bacterial species based on allelic differences in a small set of genes. As shown below, unique allele numbers are assigned to each observed variant of one of the genes in the MLST profile to measure DNA sequence variations. When the sequence is different, a new allele number is assigned. The assigned allele numbers are combined into an allelic profile that is used to characterise strains and assign sequence type (ST).

The current canonical Streptomyces Multilocus Sequence Typing Scheme provided by comprises six markers (16S rRNA, atpD, gyrB, recA, rpoB and trpB) and 236 sequence types (STs; only two new STs were reported since 2016).

With the recent increase in sequenced Streptomyces we wanted to answer the following questions:

Methods


Results

Interactive representations of minimum spanning trees

All interactive graphs represent minimum spanning trees with 852 sequence types and 292 connected components describing all sequences Streptomyces genomes, and all sequence types from the pubMLST database. Each node represents a unique sequence type, and each edge corresponds to traversing from one sequence type to other by making up to five marker changes. This divison of Streptomyces into 292 components that share no marker alleles with each other implies a set of natural divisions between groups of isolates.

Here we present that organisms assigned the same species name in NCBI:

  1. May share <95% genome identity suggesting that the should be distinct species.
  2. Some genomes identified as the same species (>≈95% genome identity) with pyANI are found in diconnected minimum spanning tree components.

(pyANI genome identity plot and aligment coverage)

  1. A single connected component unites two sets of genomes that belong to a distinct candidate genera as less than 50% of their genomes are homologous, by alignment length.

(pyANI genome identity plot and aligment coverage)


If you have any questions please do not hesitate to contact me at angelika.kiepas@strath.ac.uk:envelope_with_arrow: :woman_technologist:.